Respiratory symptoms among e-cigarette users without an established smoking history in the VERITAS cohort

Prior research on e-cigarettes’ health impacts is inconclusive due to confounding by previous tobacco smoking. Studies of e-cigarette use among people without an established smoking history are informative for this question. A cross-sectional survey was administered across six geopolitical world reg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2024-11, Vol.14 (1), p.28549-10, Article 28549
Hauptverfasser: Goicoechea, Jefrrey Zamora, Boughner, Allison, Lee, Juan José Cirion, Mahajan, Aman, Yeo, Kurt, Sproga, Maris, Russell, Christopher, Coughlan, Michael, Selya, Arielle, Caci, Grazia, Caponnetto, Pasquale, Tomaselli, Venera, Polosa, Riccardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Prior research on e-cigarettes’ health impacts is inconclusive due to confounding by previous tobacco smoking. Studies of e-cigarette use among people without an established smoking history are informative for this question. A cross-sectional survey was administered across six geopolitical world regions to adults aged 18+ without a history of established cigarette smoking or regular use of other nicotine/tobacco products. Two cohorts were defined based on e-cigarette use: “Vapers Cohort” (N = 491) who used e-cigarettes in the past 7 days and “Control Cohort” (N = 247) who never regularly used e-cigarettes. Frequency of respiratory symptoms (Respiratory Symptom Evaluation Score (RSES)) were compared between cohorts, adjusting for sociodemographics. Tobacco use history and patterns of e-cigarette use was also examined. Respiratory symptoms were rare among both the Vapers and Control Cohorts: 83.3% and 88.4%, respectively, reported “rarely” or “never” experiencing all five RSES items ( p  = 0.125). The Vapers (vs. Control) Cohort reported modestly more frequent respiratory symptoms (adjusted mean RSES 1.61 vs. 1.43, respectively, p  
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-80221-8